An International Journal of Otorhinolaryngology Clinics

Register      Login

VOLUME 8 , ISSUE 3 ( September-December, 2016 ) > List of Articles

CASE REPORT

Mastoid Bone involved by Pleomorphic Adenoma

Pradipta K Parida

Keywords : Cortical mastoidectomy,Mastoid bone,Pleomorphic adenoma

Citation Information : Parida PK. Mastoid Bone involved by Pleomorphic Adenoma. Int J Otorhinolaryngol Clin 2016; 8 (3):111-112.

DOI: 10.5005/jp-journals-10003-1244

Published Online: 01-03-2007

Copyright Statement:  Copyright © 2016; The Author(s).


Abstract

How to cite this article

Vamanshankar H, Parida PK. Mastoid Bone involved by Pleomorphic Adenoma. Int J Otorhinolaryngol Clin 2016;8(3):111-112.


PDF Share
  1. Pleomorphicadenoma in unusual anatomic sites: case reports and review of literature. Acta Otorhinolaryngol Ital 2002 Jun;22(3):158–163.
  2. Clinical manifestations of recurrent parotid pleomorphic adenoma. Clin Exp Otorhinolaryngol 2009 Dec;2(4):193–197.
  3. Recurrent pleomorphic adenoma of the parotid gland: a prospective histopathological and immunohistochemical study. Laryngoscope 2004 Jan;114(1):158–163.
  4. Prognostic significance of Ki-67 and p53 as tumor markers in salivary gland malignancies in Finland: an evaluation of 212 cases. Acta Oncol 2006;45(6):669–675.
  5. Mucin expression in pleomorphic adenoma of salivary gland: a potential role for MUC1 as a marker to predict recurrence. J Clin Pathol 2004 Aug;57(8):813–821.
  6. Pleomorphic adenoma of the middle ear and mastoid with posterior fossa extension. Arch Otolaryngol Head Neck Surg 1988 Jun;114(6):676–678.
  7. A 42-year-old man with facial nerve weakness and multiple recurrent pleomorphic adenoma. Otol Neurotol 2010 Sep;31(7):1157–1159.
  8. Recurrent pleomorphic adenoma of the head and neck. Neuroradiology 1999 Apr;41(4):300–304.
  9. Surgical treatment of recurrent pleomorphic adenoma of the parotid gland: a clinical analysis of 52 patients. Head Neck 2001 Apr;23(4):311–316.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.